Literature DB >> 25666148

Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.

G Piccinelli1, F Gargiulo1, S Corbellini1, G Ravizzola1, C Bonfanti1, A Caruso1, M A De Francesco2.   

Abstract

Of 901 group B streptococcus strains analyzed, 13 (1.4%) were resistant to levofloxacin (MICs of >32 μg/ml for seven isolates, 2 μg/ml for four isolates, and 1.5 μg/ml for four isolates). Mutations in the quinolone resistance-determining regions (QRDRs) of gyrase and topoisomerase IV were identified. A double mutation involving the Ser-81 change to Leu for gyrA and the Ser-79 change to Phe or to Tyr for parC was linked to a high level of fluoroquinolone resistance. In addition, two other mutational positions in parC were observed, resulting in an Asp-83-to-Tyr substitution and an Asp-83-to-Asn substitution. Different mutations were also observed in gyrB, with unknown significance. Most levofloxacin-resistant GBS strains were of serotype Ib and belonged to sequence type 19 (ST19) and clonal complex 19 (CC-19). Most of them exhibited the epsilon gene.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25666148      PMCID: PMC4356756          DOI: 10.1128/AAC.05127-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season.

Authors:  M E Jones; D F Sahm; N Martin; S Scheuring; P Heisig; C Thornsberry; K Köhrer; F J Schmitz
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae.

Authors:  Monica Imperi; Marco Pataracchia; Giovanna Alfarone; Lucilla Baldassarri; Graziella Orefici; Roberta Creti
Journal:  J Microbiol Methods       Date:  2009-12-01       Impact factor: 2.363

3.  High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.

Authors:  Hui Wang; Chunjiang Zhao; Wenqiang He; Feifei Zhang; Liyan Zhang; Bin Cao; Ziyong Sun; Yingchun Xu; Qing Yang; Yaning Mei; Bijie Hu; Yunzhuo Chu; Kang Liao; Yunsong Yu; Zhidong Hu; Yuxing Ni
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

4.  Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1.

Authors:  Noriyuki Nagano; Yukiko Nagano; Masami Toyama; Kouji Kimura; Takashi Tamura; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Antimicrob Chemother       Date:  2011-12-29       Impact factor: 5.790

5.  False susceptibility to amikacin by VITEK 2 in Acinetobacter baumannii harboring armA.

Authors:  Sunkyung Jung; Jin Kyung Yu; Sang Hyun Shin; Kang Gyun Park; Dong Wook Jekarl; Kyungja Han; Yeon-Joon Park
Journal:  Ann Clin Lab Sci       Date:  2010       Impact factor: 1.256

6.  Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.

Authors:  M A De Francesco; S Caracciolo; F Gargiulo; N Manca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-26       Impact factor: 3.267

7.  Molecular characterization of the first fluoroquinolone resistant strains of Streptococcus agalactiae isolated in Brazil.

Authors:  Rosana Rocha Barros; Fabíola Cristina Oliveira Kegele; Geraldo Renato de Paula; Monique Araújo de Brito; Rafael Silva Duarte
Journal:  Braz J Infect Dis       Date:  2012-09-12       Impact factor: 1.949

8.  Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007.

Authors:  Tami H Skoff; Monica M Farley; Susan Petit; Allen S Craig; William Schaffner; Ken Gershman; Lee H Harrison; Ruth Lynfield; Janet Mohle-Boetani; Shelley Zansky; Bernadette A Albanese; Karen Stefonek; Elizabeth R Zell; Delois Jackson; Terry Thompson; Stephanie J Schrag
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

9.  Multilocus sequence typing system for group B streptococcus.

Authors:  Nicola Jones; John F Bohnsack; Shinji Takahashi; Karen A Oliver; Man-Suen Chan; Frank Kunst; Philippe Glaser; Christophe Rusniok; Derrick W M Crook; Rosalind M Harding; Naiel Bisharat; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Characterization of group B streptococcus isolated from women in Saitama city, Japan.

Authors:  Hiroyuki Ueno; Yoshihiko Yamamoto; Akiko Yamamichi; Koji Kikuchi; Sumie Kobori; Motonobu Miyazaki
Journal:  Jpn J Infect Dis       Date:  2012       Impact factor: 1.362

View more
  10 in total

1.  Molecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan.

Authors:  Miyuki Morozumi; Takeaki Wajima; Misako Takata; Satoshi Iwata; Kimiko Ubukata
Journal:  J Clin Microbiol       Date:  2016-08-24       Impact factor: 5.948

Review 2.  Group B Streptococcus (Streptococcus agalactiae).

Authors:  Vanessa N Raabe; Andi L Shane
Journal:  Microbiol Spectr       Date:  2019-03

3.  Fluoroquinolone Resistance among Clonal Complex 1 Group B Streptococcus Strains.

Authors:  Alefiya Neemuchwala; Sarah Teatero; Samir N Patel; Nahuel Fittipaldi
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-07-31       Impact factor: 2.471

4.  Multidrug-Resistant Streptococcus agalactiae Strains Found in Human and Fish with High Penicillin and Cefotaxime Non-Susceptibilities.

Authors:  Carmen Li; Dulmini Nanayakkara Sapugahawatte; Ying Yang; Kam Tak Wong; Norman Wai Sing Lo; Margaret Ip
Journal:  Microorganisms       Date:  2020-07-16

5.  Streptococcus agalactiae in pregnant women: serotype and antimicrobial susceptibility patterns over five years in Eastern Sicily (Italy).

Authors:  Carlo Genovese; Floriana D'Angeli; Valentina Di Salvatore; Gianna Tempera; Daria Nicolosi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-22       Impact factor: 3.267

6.  Clinical characteristics and molecular epidemiology of invasive Streptococcus agalactiae infections between 2007 and 2016 in Nara, Japan.

Authors:  Nobuyasu Hirai; Kei Kasahara; Ryuichi Nakano; Yoshihiko Ogawa; Yuki Suzuki; Miho Ogawa; Naokuni Hishiya; Akiyo Nakano; Sadahiro Ichimura; Hisakazu Yano; Masahide Yoshikawa
Journal:  PLoS One       Date:  2020-10-19       Impact factor: 3.240

7.  Molecular characterization and antimicrobial resistance of Streptococcus agalactiae isolated from pregnant women in Japan, 2017-2021.

Authors:  Mitsuyo Kawaguchiya; Noriko Urushibara; Meiji Soe Aung; Shigeki Shimada; Mayumi Nakamura; Masahiko Ito; Satoshi Habadera; Nobumichi Kobayashi
Journal:  IJID Reg       Date:  2022-07-14

8.  The landscape of antimicrobial resistance in the neonatal and multi-host pathogen group B Streptococcus: review from a One Health perspective.

Authors:  Laura M A Oliveira; Leandro C Simões; Natalia S Costa; Ruth N Zadoks; Tatiana C A Pinto
Journal:  Front Microbiol       Date:  2022-07-28       Impact factor: 6.064

Review 9.  Endogenous endophthalmitis caused by group B streptococcus; case reports and review of 35 reported cases.

Authors:  Masaaki Yoshida; Shunji Yokokura; Takashi Nishida; Kiyofumi Mochizuki; Takashi Suzuki; Kazuichi Maruyama; Takaaki Otomo; Koji M Nishiguchi; Hiroshi Kunikata; Toru Nakazawa
Journal:  BMC Ophthalmol       Date:  2020-03-31       Impact factor: 2.209

10.  Features of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia.

Authors:  Musa Mohammed Ali; Yimtubezinash Woldeamanuel; Daniel Asrat; Demissie Assegu Fenta; Bernard Beall; Stephanie Schrag; Lesley McGee
Journal:  BMC Infect Dis       Date:  2020-11-16       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.